Eli Lilly & Co. (LLY)

1063.56 -21.63 (-1.99%) USD  |  NYSE  |  Jan 09, 16:00
1065.00 +1.44 (+0.14%) Pre-Market: 07:49
More

Eli Lilly Non-Current Deferred Revenue (Quarterly)

Non-Current Deferred Revenue (Quarterly) Chart

View Non-Current Deferred Revenue (Quarterly) for LLY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Non-Current Deferred Revenue (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Non-Current Deferred Revenue (Quarterly) Benchmarks

View Non-Current Deferred Revenue (Quarterly) Benchmarks
Start Trial
Amgen, Inc. --
Regeneron Pharmaceuticals, Inc. Upgrade
Adverum Biotechnologies, Inc. --
Viking Therapeutics, Inc. --
Moderna, Inc. Upgrade